Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1988 Feb 1;249(3):857–863. doi: 10.1042/bj2490857

Heparin uncouples alpha 2-adrenoceptors from the Gi-protein in membranes of human platelets.

B Willuweit 1, K Aktories 1
PMCID: PMC1148785  PMID: 2833229

Abstract

The influence of heparin was studied on the inhibitory regulation of adenylate cyclase in human platelet membranes. Heparin blocked the adrenaline-induced inhibition of adenylate cyclase and the stimulation of GTP hydrolysis with half-maximal and maximal efficiency at 0.3 and 1-3 micrograms/ml, respectively. The effect of heparin was reversed by washing the membranes. Heparin did not change the number of alpha-adrenoceptors. In contrast, the affinity of the alpha-adrenoceptor for adrenaline was decreased in the presence of heparin. The pertussis toxin-catalysed ADP-ribosylation of the inhibitory guanine nucleotide-binding Gi-protein was not altered by heparin. Heparin also abolished the inhibition of adenylate cyclase caused by GTP itself. The data indicate that heparin can impair the hormone-induced inhibition of adenylate cyclase and the stimulation of GTP hydrolysis and suggest that the effects of heparin are caused by an action at the Gi-protein of the adenylate cyclase system.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aktories K., Bärmann M., Ohishi I., Tsuyama S., Jakobs K. H., Habermann E. Botulinum C2 toxin ADP-ribosylates actin. Nature. 1986 Jul 24;322(6077):390–392. doi: 10.1038/322390a0. [DOI] [PubMed] [Google Scholar]
  2. Aktories K., Jakobs K. H. Epinephrine inhibits adenylate cyclase and stimulates a GTPase in human platelet membranes via alpha-adrenoceptors. FEBS Lett. 1981 Aug 3;130(2):235–238. doi: 10.1016/0014-5793(81)81128-3. [DOI] [PubMed] [Google Scholar]
  3. Aktories K., Jakobs K. H. Ni-mediated inhibition of human platelet adenylate cyclase by thrombin. Eur J Biochem. 1984 Dec 3;145(2):333–338. doi: 10.1111/j.1432-1033.1984.tb08558.x. [DOI] [PubMed] [Google Scholar]
  4. Aktories K., Schultz G., Jakobs K. H. Adenylate cyclase inhibition and GTPase stimulation by somatostatin in S49 lymphoma cyc- variants are prevented by islet-activating protein. FEBS Lett. 1983 Jul 11;158(1):169–173. doi: 10.1016/0014-5793(83)80701-7. [DOI] [PubMed] [Google Scholar]
  5. Aktories K., Schultz G., Jakobs K. H. Regulation of adenylate cyclase activity in hamster adipocytes. Inhibition by prostaglandins, alpha-adrenergic agonists and nicotinic acid. Naunyn Schmiedebergs Arch Pharmacol. 1980 Jun;312(2):167–173. doi: 10.1007/BF00569726. [DOI] [PubMed] [Google Scholar]
  6. Amsterdam A., Reches A., Amir Y., Mintz Y., Salomon Y. Modulation of adenylate cyclase activity by sulfated glycosaminoglycans. II. Effects of mucopolysaccharides and dextran sulfate on the activity of adenylate cyclase derived from various tissues. Biochim Biophys Acta. 1978 Dec 1;544(2):273–283. doi: 10.1016/0304-4165(78)90096-x. [DOI] [PubMed] [Google Scholar]
  7. Benitz W. E., Lessler D. S., Coulson J. D., Bernfield M. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor. J Cell Physiol. 1986 Apr;127(1):1–7. doi: 10.1002/jcp.1041270102. [DOI] [PubMed] [Google Scholar]
  8. Boivin P., Galand C., Bertrand O. Interactions of the human red cell membrane tyrosine kinase with heparin. FEBS Lett. 1985 Jul 1;186(1):89–92. doi: 10.1016/0014-5793(85)81345-4. [DOI] [PubMed] [Google Scholar]
  9. Bokoch G. M., Katada T., Northup J. K., Hewlett E. L., Gilman A. G. Identification of the predominant substrate for ADP-ribosylation by islet activating protein. J Biol Chem. 1983 Feb 25;258(4):2072–2075. [PubMed] [Google Scholar]
  10. Brandt D. R., Ross E. M. Catecholamine-stimulated GTPase cycle. Multiple sites of regulation by beta-adrenergic receptor and Mg2+ studied in reconstituted receptor-Gs vesicles. J Biol Chem. 1986 Feb 5;261(4):1656–1664. [PubMed] [Google Scholar]
  11. Cassel D., Pfeuffer T. Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2669–2673. doi: 10.1073/pnas.75.6.2669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cutler L. S., Christian C. P. Inhibition of rat salivary gland adenylate cyclase by glycosaminoglycans and high molecular weight polyanions. Arch Oral Biol. 1984;29(8):629–633. doi: 10.1016/0003-9969(84)90133-x. [DOI] [PubMed] [Google Scholar]
  13. Gallagher J. T., Lyon M., Steward W. P. Structure and function of heparan sulphate proteoglycans. Biochem J. 1986 Jun 1;236(2):313–325. doi: 10.1042/bj2360313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gierschik P., Falloon J., Milligan G., Pines M., Gallin J. I., Spiegel A. Immunochemical evidence for a novel pertussis toxin substrate in human neutrophils. J Biol Chem. 1986 Jun 15;261(17):8058–8062. [PubMed] [Google Scholar]
  15. Grandt R., Aktories K., Jakobs K. H. Evidence for two GTPases activated by thrombin in membranes of human platelets. Biochem J. 1986 Aug 1;237(3):669–674. doi: 10.1042/bj2370669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jakobs K. H., Aktories K., Minuth M., Schultz G. Inhibition of adenylate cyclase. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985;19:137–150. [PubMed] [Google Scholar]
  17. Jakobs K. H., Saur W., Schultz G. Inhibition of platelet adenylate cyclase by epinephrine requires GTP. FEBS Lett. 1978 Jan 1;85(1):167–170. doi: 10.1016/0014-5793(78)81272-1. [DOI] [PubMed] [Google Scholar]
  18. Jakobs K. H., Saur W., Schultz G. Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. J Cyclic Nucleotide Res. 1976 Nov-Dec;2(6):381–392. [PubMed] [Google Scholar]
  19. Mohammad S. F., Anderson W. H., Smith J. B., Chuang H. Y., Mason R. G. Effects of heparin on platelet aggregation and release and thromboxane A2 production. Am J Pathol. 1981 Aug;104(2):132–141. [PMC free article] [PubMed] [Google Scholar]
  20. Reches A., Eldor A., Salomon Y. The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets. Thromb Res. 1979;16(1-2):107–116. doi: 10.1016/0049-3848(79)90274-3. [DOI] [PubMed] [Google Scholar]
  21. Salomon Y., Amir Y., Azulai R., Amsterdam A. Modulation of adenylate cyclase activity by sulfated glycosaminoglycans. I. Inhibition by heparin of gonadotrophin-stimulated ovarian adenylate cyclase. Biochim Biophys Acta. 1978 Dec 1;544(2):262–272. doi: 10.1016/0304-4165(78)90095-8. [DOI] [PubMed] [Google Scholar]
  22. Sternweis P. C., Robishaw J. D. Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J Biol Chem. 1984 Nov 25;259(22):13806–13813. [PubMed] [Google Scholar]
  23. Thurn A. L., Underhill C. B. Heparin-induced aggregation of lymphoid cells. J Cell Physiol. 1986 Mar;126(3):352–358. doi: 10.1002/jcp.1041260305. [DOI] [PubMed] [Google Scholar]
  24. Tsai S. C., Adamik R., Kanaho Y., Hewlett E. L., Moss J. Effects of guanyl nucleotides and rhodopsin on ADP-ribosylation of the inhibitory GTP-binding component of adenylate cyclase by pertussis toxin. J Biol Chem. 1984 Dec 25;259(24):15320–15323. [PubMed] [Google Scholar]
  25. Walseth T. F., Johnson R. A. The enzymatic preparation of [alpha-(32)P]nucleoside triphosphates, cyclic [32P] AMP, and cyclic [32P] GMP. Biochim Biophys Acta. 1979 Mar 28;562(1):11–31. doi: 10.1016/0005-2787(79)90122-9. [DOI] [PubMed] [Google Scholar]
  26. Wolf H., Glassl H., Nowack H., Wick G. Identification of binding site for heparin and other polysulfated glycosaminoglycans on human thrombocytes. Int Arch Allergy Appl Immunol. 1986;80(3):231–238. doi: 10.1159/000234058. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES